Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00049374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: oblimersen sodium
DRUG: dexamethasone
DRUG: thalidomide

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]